Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The antigen-specific adaptive immune response is a highly specialized immune process triggered when the body encounters an antigen, such as a viral or pathogen-derived protein. This response is mediated by B lymphocytes (producing antibodies specific to the antigen) and T lymphocytes (helping activate other immune cells or killing infected cells), leading to elimination of the pathogen and the development of immunological memory. This process forms the basis for vaccine efficacy, as vaccines deliver the encoded antigen to stimulate a protective immune memory that can be rapidly reactivated upon future exposure to the actual pathogen.
Induction of adaptive immunity through presentation of specific pathogen-derived antigens, leading to activation, proliferation, and differentiation of B and T lymphocytes that recognize the encoded protein
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Antigen-specific adaptive immune response.